Goji

-Delile

• Ubufakazi obanele bokukala ukusebenza kwe ...
• Ukuqapha okukhethekile nezixwayiso:

IGoji isitshalo esikhula esifundeni saseMedithera nasezingxenyeni ezithile zase-Asia. Amajikijolo namagxolo ezimpande asetshenziselwa ukwenza umuthi.

IGoji isetshenziselwa izimo eziningi kubandakanya isifo sikashukela, ukwehla kwesisindo, ukuthuthukisa ikhwalithi yempilo, futhi njenge-tonic, kepha abukho ubufakazi obuhle besayensi bokuxhasa noma yikuphi kwalokhu kusetshenziswa.

Ekudleni, amajikijolo adliwa eluhlaza noma asetshenziselwa ukupheka.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze I-GOJI zimi kanje:

Ubufakazi obanele bokukala ukusebenza kwe ...

• Isifo sikashukela. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha ama-carbohydrate ezithelweni zejiji kabili nsuku zonke izinyanga ezintathu kunciphisa ushukela wegazi ngemuva kokudla kubantu abanesifo sikashukela. Kungasebenza kahle kubantu abangathathi umuthi wesifo sikashukela.
• Amehlo omile. Ucwaningo lwakuqala lukhombisa ukuthi ukusebenzisa amaconsi wamehlo nokuphuza isiphuzo esiqukethe izithelo zejiji nezinye izithako zenyanga eyodwa kungathuthukisa izimpawu zamehlo omile kangcono kunokusebenzisa amaconsi wamehlo uwedwa. Akwaziwa ukuthi inzuzo ingenxa yezithelo ze-goji, ezinye izithako, noma inhlanganisela.
• Izinga lempilo. Olunye ucwaningo lwakuqala lukhombisa ukuthi ukuphuza ijusi le-goji kuze kube yizinsuku ezingama-30 kuthuthukisa izindlela ezahlukahlukene zempilo. Amandla, ikhwalithi yokulala, ukusebenza kwengqondo, ukuhlala wamathumbu, imizwa, kanye nemizwa yokwaneliseka kubonakala kuthuthuka. Inkumbulo yesikhashana esifushane nokubona kwamehlo akukwenzi.
• Ukwehla kwesisindo. Ucwaningo lwakuqala lukhombisa ukuthi ukuphuza ijusi yejiji amasonto ama-2 ngenkathi ukunciphisa umzimba nokuvivinya umzimba kunciphisa usayizi okhalweni kubantu abadala abakhuluphele kangcono kunokudla nokuzivocavoca wedwa. Kodwa ukuphuza ijusi akuqhubeki kuthuthukisa isisindo noma amafutha omzimba.
• Izinkinga zokujikeleza kwegazi.
• Umdlavuza.
• Isiyezi.
• Imfiva.
• Umfutho wegazi ophezulu.
• Umalaleveva.
• Ukukhala ezindlebeni (tinnitus).
• Izinkinga zocansi (ukungabi namandla).
• Ezinye izimo.

Kudingeka ubufakazi obuningi ukukala ukusebenza kwe-goji kulokhu kusetshenziswa.

IGoji iqukethe amakhemikhali angasiza ekwehliseni umfutho wegazi noshukela wegazi. IGoji ingasiza futhi ekuvuseleleni amasosha omzimba nokuvikela izitho emonakalweni we-oxidative.

UGoji unjalo OKUNGENZEKA UKUPHEPHA lapho ithathwa ngokufanele ngomlomo, isikhathi esifushane. Isetshenziswe ngokuphepha izinyanga ezi-3. Ezimweni ezingavamile kakhulu, izithelo zejiji zingadala ukwanda kokukhanya kwelanga, ukulimala kwesibindi, kanye ne-allergen reaction.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Akwanele okwaziwayo ngokuphepha kokusebenzisa i-goji ngesikhathi sokukhulelwa nokuncelisa. Kukhona okunye ukukhathazeka ngokuthi isithelo se-goji singadala ukuthi isibeletho sivumelane. Kepha lokhu akubikiwe kubantu. Kuze kube kwaziwa okuningi, hlala ohlangothini oluphephile futhi ugweme ukusetshenziswa.

Ukungezwani komzimba namaprotheni emikhiqizweni ethile: I-Goji ingadala ukungezwani komzimba nabantu abaphikisana nogwayi, amapentshisi, utamatisi namantongomane.

Isifo sikashukela: UGoji angawehlisa ushukela egazini. Kungadala ukuthi ushukela wegazi wehle kakhulu uma uthatha imishanguzo yesifo sikashukela. Bheka amazinga kashukela egazi ngokucophelela.

Umfutho wegazi ophansi: IGoji ingase yehlise umfutho wegazi. Uma ingcindezi yakho yegazi isivele iphansi, ukuthatha i-goji kungayenza yehle kakhulu.

Maphakathi

Qaphela ngale nhlanganisela.

Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 2C9 (CYP2C9))

Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. IGoji ingahle yehlise ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Ukuthatha i-goji kanye neminye imithi eyehliswe yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yeminye imithi. Ngaphambi kokuthatha i-goji, khuluma nomhlinzeki wakho wezokunakekelwa kwezempilo uma uthatha noma yimiphi imithi eshintshwa yisibindi.

Eminye imishanguzo eguqulwa isibindi ifaka i-amitriptyline (Elavil), diazepam (Valium), zileuton (Zyflo), celecoxib (Celebrex), diclofenac (Voltaren), fluvastatin (Lescol), glipizide (Glucotrol), ibuprofen (Advil, Motrin) , irbesartan (Avapro), losartan (Cozaar), phenytoin (Dilantin), piroxicam (Feldene), tamoxifen (Nolvadex), tolbutamide (Tolinase), torsemide (Demadex), warfarin (Coumadin), nabanye.

Imithi yesifo sikashukela (Imithi elwa nesifo sikashukela)

IGoji inganciphisa ushukela wegazi. Imithi yesifo sikashukela nayo isetshenziselwa ukwehlisa ushukela egazini. Ukuthatha i-goji kanye nemithi yesifo sikashukela kungadala ukuthi ushukela wegazi lakho wehle kakhulu. Bheka ushukela wegazi lakho eduze. Umthamo wemithi yakho yesifo sikashukela ungadinga ukuguqulwa.

Eminye imithi esetshenziselwa isifo sikashukela ifaka i-glimepiride (Amaryl), i-glyburide (i-DiaBeta, i-Glynase PresTab, i-Micronase), i-insulin, i-pioglitazone (i-Actos), i-rosiglitazone (i-Avandia), i-chlorpropamide (i-Diabinese), i-glipizide (i-Glucotrol), i-tolbutamide (i-Orinase), .

Imithi yokwelapha umfutho wegazi ophakeme (Imithi efuthayo)

Amagxolo ezimpande zikaGoji abukeka enciphisa umfutho wegazi. Ukuthatha amagxolo ezimpande ze-goji kanye nemithi yomfutho wegazi ophakeme kungadala ukuthi umfutho wegazi lakho wehle kakhulu. Isithelo seGoji asibonakali sithinta umfutho wegazi.

Eminye imishanguzo yomfutho wegazi ophakeme ifaka i-captopril (Capoten), i-enalapril (i-Vasotec), i-losartan (i-Cozaar), i-valsartan (i-Diovan), i-diltiazem (i-Cardizem), i-Amlodipine (i-Norvasc), i-hydrochlorothiazide (i-HydroDIURIL), i-furosemide (i-Lasix), neminye eminingi .

I-Warfarin (Coumadin)

I-Warfarin (i-Coumadin) isetshenziselwa ukunciphisa ukubamba kwegazi. IGoji ingakhuphula ukuthi i-warfarin (Coumadin) isemzimbeni omude kangakanani. Lokhu kungakhuphula amathuba okulimala nokopha. Qiniseka ukuthi uhlolwa igazi lakho njalo. Umthamo we-warfarin yakho (i-Coumadin) ungadinga ukuguqulwa.

Amakhambi nezengezo ezinganciphisa umfutho wegazi

Amagxolo ezimpande zikaGoji anganciphisa umfutho wegazi. Ukuyisebenzisa kanye namanye amakhambi nezengezo zokwehlisa umfutho wegazi kungehlisa umfutho wegazi kakhulu. Eminye yale mikhiqizo ifaka i-danshen, i-ginger, i-Panax ginseng, i-turmeric, i-valerian, neminye.

Amakhambi nezithasiselo ezingehlisa ushukela egazini

UGoji angawehlisa ushukela egazini. Ukuyisebenzisa kanye namanye amakhambi kanye nezengezo ezinciphisa ushukela wegazi kungehlisa ushukela wegazi ngokweqile. Eminye yale mikhiqizo kubalwa ibhece, i-ginger, i-goat's rue, i-fenugreek, i-kudzu, i-willow bark neminye.

Akukho ukuxhumana okwaziwayo nokudla.

Umthamo ofanele we-goji uncike ezintweni eziningana ezifana nobudala bomsebenzisi, impilo, nezinye izimo eziningana. Ngalesi sikhathi alukho ulwazi olwanele lwesayensi lokunquma uhla olufanele lwamanani we-goji. Khumbula ukuthi imikhiqizo yemvelo ayihlali iphephile njalo futhi imithamo ingabaluleka. Qiniseka ukuthi ulandela izinkomba ezifanele kumalebula womkhiqizo futhi uthintane nosokhemisi wakho noma udokotela noma omunye uchwepheshe wezokunakekelwa kwempilo ngaphambi kokusebenzisa.

Baies de Goji, Baies de Lycium, Barberry Matrimony Vine, Chinese Boxthorn, Chinese Wolfberry, Di Gu Pi, Digupi, Épine du Christ, Fructus Lychii Chinensis, Fructus Lycii, Fructus Lycii Berry, Fruit de Lycium, Goji, Goji Berry, Goji Chinois , Goji de l'Himalaya, Goji Juice, Gougi, Gou Qi Zi, Gouqizi, Jus de Goji, Kuko, Lichi, Licium Barbarum, Litchi, Lyciet, Lyciet Commun, Lyciet de Barbarie, Lyciet de Chine, Lycii Berries, Lycii Chinensis, Izithelo ze-Lycii, i-Lycium barbarum, i-Lycium chinense, i-Lycium Fruit, i-Matrimony Vine, i-Ning Xia Gou Qi, i-Wolfberry, i-Wolf berry.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.

1. UPotterat O. Goji (uLycium barbarum noL. Chinense): I-Phytochemistry, ikhemisi nokuphepha ngokubheka ukusetshenziswa kwendabuko kanye nokuthandwa kwakamuva. UPlanta Med 2010; 76: 7-19. Buka okungaqondakali.
2. UCheng J, Zhou ZW, Sheng HP, He LJ, Fan XW, He ZX, et al. Ukuvuselelwa okusekelwe ebufakazini ngemisebenzi yezemithi kanye nezinhloso zamangqamuzana ezinokwenzeka zeLycium barbarum polysaccharides. Izidakamizwa Des Devel Ther. 2014; 17: 33-78. Buka okungaqondakali.
3. UCai H, Liu F, Zuo P, Huang G, Ingoma Z, Wang T, et al. Ukusetshenziswa okusebenzayo kokusebenza kahle kwesifo sikashukela seLycium barbarum polysaccharide ezigulini ezinesifo sikashukela sohlobo 2. UMed Chem. 2015; 11: 383-90. Buka okungaqondakali.
4. ULarramendi CH, uGarcía-Abujeta JL, uVicario S, uGarcía-Endrino A, uLópez-Matas MA, uGarcía-Sedeño MD, et al. Amajikijolo eGoji (iLycium barbarum): Ubungozi bokungazwani komzimba nabantu abanokungezwani kokudla. J Investig Allergol Umtholampilo Immunol. 2012; 22: 345-50. Buka okungaqondakali.
5. UJiménez-Encarnación E, uRíos G, Muñoz-Mirabal A, Vilá LM. I-euforia-indened hepatitis ebukhali esigulini esine-scleroderma. I-BMJ Case Rep 2012; 2012. Buka okungaqondakali.
6. Amagase H, Sun B Nance DM. Izifundo zomtholampilo zokwenza ngcono inhlalonhle ejwayelekile ngejusi yezithelo yeLycium barbarum. UPlanta Med 2008; 74: 1175-1176.
7. UKim, H. P., Kim, S. Y., Lee, E. J., Kim, Y. C., noKim, Y. C. Zeaxanthin dipalmitate ovela eLycium chinense unomsebenzi wokuvikela izifo. I-Res Commun. UMol .Pathol Pharmacol 1997; 97: 301-314. Buka okungaqondakali.
8. I-Gribanovski-Sassu, O., Pellicciari, R., neCataldi, i-Hiughez C. Imibala yezinhlamvu zeLycium europaeum: umphumela wonyaka ekwakhiweni kwe-zeaxanthin ne-lutein. U-Ann Ist Super uSanita 1969; 5: 51-53. Buka okungaqondakali.
9. UWineman, E., Portugal-Cohen, M., Soroka, Y., Cohen, D., Schlippe, G., Voss, W., Brenner, S., Milner, Y., Hai, N., noMa ' noma, Z. Photo-umonakalo umphumela wokuvikela wemikhiqizo emibili yobuso, equkethe inxanxathela eyingqayizivele yamaminerali oLwandle Olufile nezenzo zeHimalaya. J.Cosmet.I-dermatol. 2012; 11: 183-192. Buka okungaqondakali.
10. UPaul Hsu, uC. H., uNance, D. M., no-Amagase, H. Ukuhlaziywa kwemeta kokuthuthuka kwemitholampilo yenhlalakahle jikelele yi-standard standard yeLycium. J.Med.Ukudla 2012; 15: 1006-1014. Buka okungaqondakali.
11. UFranco, M., Monmany, J., Domingo, P., noTurbau, M. [Isifo sokusha kwesibindi sokuzivikela esibangelwa ukusetshenziswa kwamajikijolo eGoji]. IMed.Clin. (Barc.) 9-22-2012; 139: 320-321. Buka okungaqondakali.
12. UVidal, K., Bucheli, P., Gao, Q., Moulin, J., Shen, LS, Wang, J., Blum, S., noBenyacoub, J.Imiphumela yokuqothulwa komzimba yokungezelelwa kokudla nge-wolfberry esekwe ebisi ukwakheka kwabantu asebekhulile abanempilo: isilingo esilawulwa ngokungahleliwe, esingaboni kahle, esilawulwa yi-placebo. Ukuvuselelwa.Izimali. 2012; 15: 89-97. Buka okungaqondakali.
13. UMonzon, Ballarin S., Lopez-Matas, M. A., Saenz, Abad D., Perez-Cinto, N., noCarnes, J. Anaphylaxis ehambisana nokufakwa kwamajikijolo eGoji (ILiccium barbarum). I-J.Investig.I-Allergol.Clin.Immunol. 2011; 21: 567-570. Buka okungaqondakali.
14. USin, H. P., Liu, D., noLam, D. S. Ukuguqulwa kwendlela yokuphila, izakhamzimba ezinomsoco kanye namavithamini okwehla okuhlobene nobudala be-macular. Acta Ophthalmol. 2013; 91: 6-11. Buka okungaqondakali.
15. U-Amagase, H. noNance, D. M. I-Lycium barbarum yandisa izindleko zekhalori futhi yehlise ubude bezinqe emadodeni nakwabesifazane abakhuluphele ngokweqile: isifundo somshayeli. J. Amoll. Umsoco. 2011; 30: 304-309. Buka okungaqondakali.
16. Bucheli, P., Vidal, K., Shen, L., Gu, Z., Zhang, C., Miller, L. E., noWang, J. Goji berry imiphumela kuzici ze-macular namazinga e-plasma antioxidant. I-Optom.Vis.Sci. 2011; 88: 257-262. Buka okungaqondakali.
17. Amagase, H., Sun, B., kanye noNance, D. M. Imiphumela yokuzivikela emzimbeni wejusi yezithelo yaseLycium barbarum ejwayelekile ezifundweni zabantu abadala baseChina abanempilo. J.Med. Ukudla 2009; 12: 1159-1165. Buka okungaqondakali.
18. U-Wei, D., Li, Y. H., noZhou, W. Y. [Ukuqaphela umphumela wokwelapha we-runmushu uketshezi lomlomo ekwelapheni i-xerophthalmia kwabesifazane be-postmenopausal]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. U-2009; 29: 646-649. Buka okungaqondakali.
19. UMiao, Y., Xiao, B., Jiang, Z., Guo, Y., Mao, F., Zhao, J., Huang, X., noGoo, J. Ukukhula kokuvimbela nokuboshwa komjikelezo weseli kwesisu somuntu amangqamuzana omdlavuza yiLycium barbarum polysaccharide. IMed.Oncol. 2010; 27: 785-790. Buka okungaqondakali.
20. Amagase, H., Sun, B., noBorek, C. Ijusi leLycium barbarum (goji) liyathuthuka kuma-vivo antioxidant biomarkers ku-serum yabantu abadala abaphilile. Ukudla okunomsoco. U-2009; 29: 19-25. Buka okungaqondakali.
21. U-Lu, C. X. no-Cheng, B. Q. [Imiphumela ye-Radiosensitizing ye-Lycium barbarum polysaccharide yomdlavuza ka-Lewis wamaphaphu]. Zhong.Xi.Yi.Jie.Iye.Za Zhi. 1991; 11: 611-2, 582. Buka okungaqondakali.
22. Chang, R. C. and So, K. F. Use of Anti-aging Herbal Medicine, Lycium barbarum, Against Aging-associated Izifo. Yini Esiyaziyo Kuze Kube Manje? Iseli Mol. Neurobiol. 8-21-2007; Buka okungaqondakali.
23. Chan, HC, Chang, RC, Koon-Ching, Ip A., Chiu, K., Yuen, WH, Zee, SY, and So, KF Neuroprotective imiphumela yeLycium barbarum Lynn ekuvikeleni amaseli e-retinal ganglion ku-ocular hypertension model of i-glaucoma. I-Exp Neurol. 2007; 203: 269-273. Buka okungaqondakali.
24. I-Adams, M., Wiedenmann, M., Tittel, G., neBauer, R. HPLC-MS ilandelela ukuhlaziywa kwe-atropine kumajikijolo eLycium barbarum. I-Phytochem.Anal. 2006; 17: 279-283. Buka okungaqondakali.
25. UChao, J. C., Chiang, S. W., Wang, C., Tsai, Y.H, noWu, M. S. Amanzi ashisayo akhishwe eLycium barbarum naseRehmannia glutinosa avimbela ukwanda futhi abangele i-apoptosis yamaseli e-hepatocellular carcinoma. Umhlaba J Gastroenterol 7-28-2006; 12: 4478-4484. Buka okungaqondakali.
26. UBenzie, I. F., Chung, W. Y., Wang, J., Richelle, M., noBucheli, P. Ukwandiswa kokutholakala kwe-zeaxanthin ekwakhiweni kobisi lwe-wolfberry (Gou Qi Zi; Fructus barbarum L.). UBr J Nutriti 2006; 96: 154-160. Buka okungaqondakali.
27. Yu, M. S., Ho, Y. S., Ngakho-ke, K. F., Yuen, W. H., no Chang, R. C. Imiphumela yokuvikela i-Lycium barbarum ekunciphiseni ukucindezeleka ku-endoplasmic reticulum. I-Int J Mol. Medied 2006; 17: 1157-1161. Buka okungaqondakali.
28. UPeng, Y., Ma, C., Li, Y., Leung, K. S., Jiang, Z. H., noZhao, Z. Ukulinganiswa kwe-zeaxanthin dipalmitate kanye ne-carotenoids ephelele kwizithelo zeLycium (Fructus Lycii). Ukudla kwezitshalo Hum. Nutrut 2005; 60: 161-164. Buka okungaqondakali.
29. UZhao, R., Li, Q., noXiao, B. Umphumela weLycium barbarum polysaccharide ekuthuthukiseni ukumelana ne-insulin kumagundane e-NIDDM. Yakugaku Zasshi 2005; 125: 981-988. Buka okungaqondakali.
30. UToyada-Ono, Y., Maeda, M., Nakao, M., Yoshimura, M., Sugiura-Tomimori, N., Fukami, H., Nishioka, H., Miyashita, Y., noKojo, S. A inoveli ka-vitamin C analog, 2-O- (beta-D-Glucopyranosyl) ascorbic acid: ukuhlolwa kwe-enzymatic synthesis kanye nomsebenzi we-biological. J Biosci.I-Bioeng. 2005; 99: 361-365. Buka okungaqondakali.
31. U-Lee, D. G., Jung, H. J., no-Woo, E. R. Impahla elwa namagciwane ka- (+) - i-lyoniresinol-3alpha-O-beta-D-glucopyranoside ehlukaniswe namagxolo ezimpande zeLycium chinense Miller emelene namagciwane e-pathogenic abantu. I-Arch Pharm Res 2005; 28: 1031-1036. Buka okungaqondakali.
32. He, Y. L., Ying, Y., Xu, Y. L., Su, J. F., Luo, H., noWang, H. F. [Imiphumela yeLycium barbarum polysaccharide kwi-tumor microenvelo T-lymphocyte subsets namaseli we-dendritic kumagundane athwala i-H22]. Zhong.Xi.Yi.Jie.Iye.Xue.Bao. 2005; 3: 374-377. Buka okungaqondakali.
33. UGong, H., Shen, P., Jin, L., Xing, C., noTang, F. Imiphumela yokwelashwa yeLycium barbarum polysaccharide (LBP) kwimisebe ye-irradiation noma ye-chemotherapy-eyenzelwe i-myelosuppressive. I-Cancer Biother.I-Radiopharm. 2005; 20: 155-162. Buka okungaqondakali.
34. UZhang, M., Chen, H., Huang, J., Li, Z., Zhu, C., noZhang, S. Umphumela we-lycium barbarum polysaccharide kumaseli e-hepatoma QGY7703 amaseli: ukuvimbela ukwanda nokufakwa kwe-apoptosis. Impilo Sci 3-18-2005; 76: 2115-2124. Buka okungaqondakali.
35. U-Hai-Yang, G., Ping, S., Li, J. I., Chang-Hong, X., noFu, T. Imiphumela yokwelashwa kweLycium barbarum polysaccharide (LBP) ku-mitomycin C (MMC) -yenze amagundane e-myelosuppressive. UJ Exp Ther Oncol 2004; 4: 181-187. Buka okungaqondakali.
36. UCheng, C. Y., Chung, W. Y., Szeto, Y.T, noBenzie, I. F. Ukuzila impendulo ye-plasma zeaxanthin kuFructus barbarum L. (wolfberry; Kei Tze) esivivinyweni sokusekelwa kwabantu esisekelwa ekudleni. Br. J Umsoco. 2005; 93: 123-130. Buka okungaqondakali.
37. UZhao, H., Alexeev, A., Chang, E., Greenburg, G., noBojanowski, K. I-Lycium barbarum glycoconjugates: umphumela esikhunjeni somuntu nakuma-fibroblast akhiqizwayo. I-Phytomedicine 2005; 12 (1-2): 131-137. Buka okungaqondakali.
38. Luo, Q., Cai, Y., Yan, J., Sun, M., no Corke, H. Hypoglycemic kanye nemiphumela ye-hypolipidemic kanye nomsebenzi we-antioxidant wezithelo ezikhishwe eLycium barbarum. Impilo Sci 11-26-2004; 76: 137-149. Buka okungaqondakali.
39. U-Lee, D. G., Park, Y., Kim, M. R., Jung, H. J., Seu, Y. B., Hahm, K. S., noWoo, E. R. Imiphumela yokulwa nesikhunta yama-phenolic amides ahlukaniswe namagxolo ezimpande zeLycium chinense. I-Biotechnol. Lett 2004; 26: 1125-1130. Buka okungaqondakali.
40. UBreithaupt, DE, Weller, P., Wolters, M., noHahn, A. Ukuqhathaniswa kwezimpendulo ze-plasma ezifundweni zabantu ngemuva kokungeniswa kwe-3R, 3R'-zeaxanthin dipalmitate kusuka ku-wolfberry (i-Lycium barbarum) ne-3R, 3R engaqinisekisiwe. '-zeaxanthin kusetshenziswa i-chiral high-performance liquid chromatography. Br. J Umsoco. 2004; 91: 707-713. Buka okungaqondakali.
41. UGan, L., Hua, Zhang S., Liang, Yang, X, no-Bi, Xu H.Ukuzivocavoca umzimba nokusebenza kwe-antitumor yinkimbinkimbi ye-polysaccharide-protein evela eLycium barbarum. I-Immunopharmacol. 2004; 4: 563-569. Buka okungaqondakali.
42. UToyoda-Ono, Y., Maeda, M., Nakao, M., Yoshimura, M., Sugiura-Tomimori, N., noFukami, H. 2-O- (beta-D-Glucopyranosyl) ascorbic acid, inoveli i-ascorbic acid analogue ehlukaniswe nezithelo zeLycium. J Agric Ukudla Chem 4-7-2004; 52: 2092-2096. Buka okungaqondakali.
43. UHuang, X., Yang, M., Wu, X., noJan, J. [Funda ngesenzo sokuvikela i-lycium barbarum polysaccharides kokufakwa kwe-DNA kwamaseli esende kumagundane]. U-Wei Sheng Yan. UJiu. 2003; 32: 599-601. Buka okungaqondakali.
44. Luo, Q., Yan, J., noZhang, S. [Ukuhlukaniswa nokuhlanzwa kweLycium barbarum polysaccharides nomphumela wayo wokulwa nokukhathala]. U-Wei Sheng Yan. UJiu. 3-30-2000; 29: 115-117. Buka okungaqondakali.
45. UGan, L., Wang, J., noZhang, S. [Ukuvimbela ukukhula kwamaseli wegazi lomuntu yiLycium barbarum polysaccharide]. U-Wei Sheng Yan. UJiu. 2001; 30: 333-335. Buka okungaqondakali.
46. Liu, X. L., Sun, J. Y., Li, H. Y., Zhang, L., noQian, B. C. [Ukukhishwa nokuhlukaniswa kwento esebenzayo yokuvimbela ukwanda kwamangqamuzana e-PC3 ku-vitro esithelweni seLycium barbarum L.]. Zhongguo Zhong.Yao Za Zhi. 2000; 25: 481-483. Buka okungaqondakali.
47. UChin, Y. W., Lim, S. W., Kim, S. H., Shin, D. Y., Suh, Y. G., Kim, Y. B., Kim, YC, noKim, J. Hepatoprotective pyrrole derivatives wezithelo zeLycium chinense. UMed Chem Lett 1-6-2003; 13: 79-81. Buka okungaqondakali.
48. U-Wang, Y., Zhao, H., Sheng, X., Gambino, P. E., Costello, B., noBojanowski, K. Umphumela wokuvikela we-Fructus Lycii polysaccharides ngokumelene nesikhathi kanye nomonakalo owenziwe yi-hyperthermia ekhukhweni le-seminiferous epithelium. J Ethnopharmacol. 2002; 82 (2-3): 169-175. Buka okungaqondakali.
49. U-Huang, Y., Lu, J., Shen, Y., no-Lu, J. [Imiphumela yokuvikela yama-flavonoid aphelele avela ku-Lycium Barbarum L. ku-lipid peroxidation ye-mitochondria yesibindi namaseli abomvu egazi kumagundane]. U-Wei Sheng Yan. UJiu. 3-30-1999; 28: 115-116. Buka okungaqondakali.
50. UKim, H. P., Lee, E. J., Kim, Y. C., Kim, J., Kim, H. K., Park, J. H., Kim, S. Y., noKim, Y. C. Zeaxanthin dipalmitate from Lycium chinense izithelo sehlisa ulingo olubangelwa i-hepatic fibrosis kumagundane. IBiol Pharm Bull. 2002; 25: 390-392. Buka okungaqondakali.
51. UKim, S. Y., Lee, E. J., Kim, H. P., Kim, Y. C., Moon, A., noKim, Y. C. I-cerebroside yenoveli evela ku-lycii fructus igcina uhlelo lwe-hepatic glutathione redox kumasiko aphambili ama-hepatocytes amagundane. IBiol Pharm Bull. 1999; 22: 873-875. Buka okungaqondakali.
52. Fu, J. X. [Ukukala kwe-MEFV ezimeni ezingama-66 zesifuba somoya esigabeni sokululama nangemva kokwelashwa ngamakhambi aseChina]. Zhong.Xi.Yi.Jie.Iye.Za Zhi. 1989; 9: 658-9, 644. Buka okungaqondakali.
53. I-Weller, P. ne-Breithaupt, D. E. Ukuhlonza kanye ne-quantification ye-zeaxanthin esters ezitshalweni ezisebenzisa i-liquid chromatography-mass spectrometry. J.Agric. Ukudla Chem. 11-19-2003; 51: 7044-7049. Buka okungaqondakali.
54. UGomez-Bernal, S., Rodriguez-Pazos, L., Martinez, F. J., Ginarte, M., Rodriguez-Granados, M.T, noToribio, J. Systemensitivityitivity ngenxa yamajikijolo eGoji. Photodermatol.Photoimmunol.Isithombe. 2011; 27: 245-247. Buka okungaqondakali.
55. Larramendi, CH, Garcia-Abujeta, JL, Vicario, S., Garcia-Endrino, A., Lopez-Matas, MA, Garcia-Sedeno, MD, and Carnes, J. Goji amajikijolo (Lycium barbarum): ingozi yokungezwani komzimba kubantu abanokungezwani komzimba nokudla. I-J.Investig.I-Allergol.Clin.Immunol. 2012; 22: 345-350. Buka okungaqondakali.
56. ICarnes, J., de Larramendi, CH, Ferrer, A., Huertas, AJ, Lopez-Matas, MA, Pagan, JA, Navarro, LA, Garcia-Abujeta, JL, Vicario, S., noPena, M. Muva nje. kwethulwa ukudla njengemithombo emisha ye-allergenic: ukuzwela kumajikijolo eGoji (iLycium barbarum). Ukudla Chem. 4-15-2013; 137 (1-4): 130-135. Buka okungaqondakali.
57. URivera, C. A., Ferro, C. L., Bursua, A. J., noGerber, B. S. Ukuxhumana okungenzeka phakathi kweLycium barbarum (goji) ne-warfarin. I-Pharmacotherapy 2012; 32: e50-e53. Buka okungaqondakali.
58. Amagase H, Nance DM. Ucwaningo olwenziwe ngokungahleliwe, oluyimpumputhe, olulawulwa yi-placebo, olwenziwe ngemitholampilo yemiphumela ejwayelekile yejusi yeLycium barbarum (goji) ejwayelekile, iGoChi. J Altern Complement Med 2008; 14: 403-12. Buka okungaqondakali.
59. ULeung H, uHung A, uHui AC, uKhan TY. Ukudlula ngokweqile kweWarfarin ngenxa yemiphumela engaba khona yeLycium barbarum L. Ukudla Chem Toxicol 2008; 46: 1860-2. Buka okungaqondakali.
60. ILam AY, i-Elmer GW, i-Mohutsky MA. Ukusebenzisana okungenzeka phakathi kwe-warfarin neLycium Barbarum. U-Ann Pharmacother 2001; 35: 1199-201. Buka okungaqondakali.
61. I-Huang KC. I-Pharmacology yama-Chinese Herbs. Okwesibili. IBoca Raton, FL: CRC Press, LLC 1999.
62. UKim SY, uLee EJ, uKim HP, et al. I-LCC, i-cerebroside evela ku-lycium chinense, ivikela ama-hepatocyte amagundane ayisisekelo avezwe ku-galactosamine. I-Phytother Res 2000; 14: 448-51. Buka okungaqondakali.
63. Cao GW, Yang WG, Du P. [Ukuqaphela imiphumela yokwelashwa kwe-LAK / IL-2 okuhlanganisa neLycium barbarum polysaccharides ekwelapheni iziguli ezinomdlavuza ezingama-75]. UChung Hua Chung Liu Tsa Chih 1994; 16: 428-31.Buka okungaqondakali.
64. Umsebenzi Wokucwaninga Kwezolimo. Imininingwane yolwazi kaDkt. Duke kanye ne-ethnobotanical. www.ars-grin.gov/cgi-bin/duke/farmacy2.pl?575 (Kufinyelelwe ngomhla ka-31 Januwari 2001).
65. I-Chevallier A. Encyclopedia Yemithi Engamakhambi. Okwesibili. ENew York, NY: DK Publ, Inc., 2000.
66. Law M. Tshala ama-sterol nama-stanol imajarini kanye nempilo. BMJ 2000; 320: 861-4. Buka okungaqondakali.
67. UMcGuffin M, uHobbs C, u-Upton R, uGoldberg A, ama-eds. Ibhuku le-American Herbal Products Association's Botanical Safety Handbook. IBoca Raton, FL: CRC Press, LLC 1997.

Kugcine ukubuyekezwa - 04/03/2019